Drug
Sulforaphane (broccoli sprout extract)
Sulforaphane (broccoli sprout extract) is a pharmaceutical drug with 2 clinical trials. Currently 1 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(50%)
Phase Distribution
Ph phase_2
1
50%
Ph early_phase_1
1
50%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Active, not recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (50.0%)
Phase 21 (50.0%)
Trials by Status
active_not_recruiting150%
not_yet_recruiting150%
Recent Activity
1 active trials
Showing 2 of 2
active_not_recruitingearly_phase_1
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
NCT03730649
not_yet_recruitingphase_2
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
NCT07040280
Clinical Trials (2)
Showing 2 of 2 trials
NCT03730649Early Phase 1
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
NCT07040280Phase 2
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
All 2 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 2